These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9051191)
1. Quantitative measurement of estrogen and progesterone receptors in breast lumps using image cytometry. Sarker SK; Mendiola R; Walker M; Coleman DV Anal Quant Cytol Histol; 1997 Feb; 19(1):87-91. PubMed ID: 9051191 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry. van Agthoven T; Timmermans M; Foekens JA; Dorssers LC; Henzen-Logmans SC Am J Pathol; 1994 Jun; 144(6):1238-46. PubMed ID: 7515559 [TBL] [Abstract][Full Text] [Related]
3. [Expression of oestrogen receptor-beta in invasive breast tumours]. Péter I; Számel I; Péley G Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of estrogen and progesterone receptors in benign breast diseases. Tóth J; De Sombre ER; Greene GL Zentralbl Pathol; 1991; 137(3):227-32. PubMed ID: 1931896 [TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical characteristics of mammary carcinomas with estrogen-negative and progesterone-positive receptors]. Sundblad AS; Caprarulo L Medicina (B Aires); 1996; 56(6):683-9. PubMed ID: 9284572 [TBL] [Abstract][Full Text] [Related]
6. [Human breast cancer embedded in paraffin, fixed in Bouin's fluid. Immunohistochemical analysis of estrogen and progesterone receptors]. Jacquemier J; Boudaoura T; Martin PM; Torrente M; Hassoun J Ann Pathol; 1991; 11(4):224-30. PubMed ID: 1958256 [TBL] [Abstract][Full Text] [Related]
7. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue]. Schulze MH; Buchmann J Zentralbl Gynakol; 2000; 122(2):92-5. PubMed ID: 10721188 [TBL] [Abstract][Full Text] [Related]
8. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study. Wilbur DC; Barrows GH Mod Pathol; 1993 Mar; 6(2):114-20. PubMed ID: 8097877 [TBL] [Abstract][Full Text] [Related]
9. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors. Keshgegian AA Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of C-erbB-2 and hormone receptors' status in human benign and malignant breast lesions. Goussia A; Agnantis NJ; Athanassiadou S; Stefanou D Anticancer Res; 1995; 15(5B):2313-8. PubMed ID: 8572645 [TBL] [Abstract][Full Text] [Related]
11. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Moinfar F; Okcu M; Tsybrovskyy O; Regitnig P; Lax SF; Weybora W; Ratschek M; Tavassoli FA; Denk H Cancer; 2003 Aug; 98(4):703-11. PubMed ID: 12910513 [TBL] [Abstract][Full Text] [Related]
12. [A comparative study of hormone receptors in breast cancer with quantitative immunocytochemistry and biochemistry]. Marcot I; Migeon C; Parache RM; Marchal S; Virion JM Bull Cancer; 1997 Jun; 84(6):613-8. PubMed ID: 9295864 [TBL] [Abstract][Full Text] [Related]
13. Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays. Bae YK; Gong G; Kang J; Lee A; Cho EY; Lee JS; Suh KS; Lee DW Am J Surg Pathol; 2012 Dec; 36(12):1817-25. PubMed ID: 23154769 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Gatalica Z Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507 [TBL] [Abstract][Full Text] [Related]
15. ER-negative /PR-positive breast carcinomas or technical artifacts in immunohistochemistry? Maleki Z; Shariat S; Mokri M; Atri M Arch Iran Med; 2012 Jun; 15(6):366-9. PubMed ID: 22642247 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers. Nadji M; Gomez-Fernandez C; Ganjei-Azar P; Morales AR Am J Clin Pathol; 2005 Jan; 123(1):21-7. PubMed ID: 15762276 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of estrogen and progesterone receptor and neu expression in breast carcinoma. Chu JS; Lee WJ; Chen KM; Hsu HC J Formos Med Assoc; 1994 Apr; 93(4):277-82. PubMed ID: 7914767 [TBL] [Abstract][Full Text] [Related]
18. [Western blot analysis and flow cytometric analysis of estrogen and progesterone receptors in fixed breast cancer cells]. Tao DD; Jiang M; Wu JH; Feng YD; Gong JP Ai Zheng; 2004 Mar; 23(3):339-41. PubMed ID: 15025971 [TBL] [Abstract][Full Text] [Related]
19. Cytologic diagnosis of estrogen and progesterone receptors in breast imprints. Sasaki M; Morimoto K; Koh M; Wakasa K; Haba T; Kinoshita H Acta Cytol; 2002; 46(6):1056-60. PubMed ID: 12462082 [TBL] [Abstract][Full Text] [Related]
20. Estrogen and progesterone receptors in benign breast tumors and lesions: relationship with histological and cytological features. Giani C; D'Amore E; Delarue JC; Mouriesse H; May-Levin F; Sancho-Garnier H; Breccia M; Contesso G Int J Cancer; 1986 Jan; 37(1):7-10. PubMed ID: 3000957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]